Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $143,550 - $168,456
600 Added 4.11%
15,200 $4.23 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $3.44 Million - $3.91 Million
14,600 New
14,600 $3.65 Million
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $832,950 - $1.05 Million
4,500 Added 409.09%
5,600 $1.3 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $256,388 - $292,149
1,100 New
1,100 $272,000
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $789,408 - $964,047
-2,900 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$225.08 - $271.69 $652,732 - $787,901
2,900 New
2,900 $778,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.